P14.58 Extending adjuvant temozolomide longer than six cycles doesn’t add any benefit to glioblastoma patients according to the randomized GEINO-014 TRIAL

BACKGROUND: Standard treatment of glioblastoma (GBM) is focal radiation with concomitant and adjuvant temozolomide (TMZ) for 6 cycles. The GEINO-14-01 trial (NCT02209948) investigated the role of extending adjuvant TMZ to 12 cycles in a randomized multicenter study. MATERIAL AND METHODS: Between Aug...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Balana, C, Sepulveda, J, Pineda, E, Vaz, M, Mesia, C, Fuster, J, Girones, R, Muñoz-Langa, J, Navarro, M, Alonso, M, Gil Gil, M, Herrero, A, Estival, A, Gallego, O, Peralta, S, Olier, C, Pérez-Segura, P, Covela, M, Martinez García, M, Domenech, M, Carrato, C, Sanz, C, Velarde, J, Berrocal, A, Luque, R, De las Peñas, R, Del Barco, S
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2019
Soggetti:
Poster Presentations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795970/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.293
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi